Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA‐Compliant single‐arm Meta‐Analysis of …
P Ge, A Reyila, X Li, S Liu, Y Jiang… - Journal of Clinical …, 2022 - Wiley Online Library
What is known and Objective Aflibercept, a recombinant protein designed to suppress the
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA-Compliant single-arm Meta-Analysis of …
P Ge, A Reyila, Y Bian - 2022 - repository.um.edu.mo
What is known and Objective: Aflibercept, a recombinant protein designed to suppress the
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA-Compliant single-arm Meta-Analysis of …
P Ge, A Reyila, XY Li, SY Liu… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
What is known and objective Aflibercept, a recombinant protein designed to suppress the
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA‐Compliant single‐arm Meta‐Analysis of …
P Ge, A Reyila, X Li, S Liu, Y Jiang… - Journal of Clinical …, 2022 - search.ebscohost.com
What is known and Objective: Aflibercept, a recombinant protein designed to suppress the
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients …
Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA-Compliant single-arm Meta-Analysis of …
P Ge, A Reyila, XY Li, SY Liu, YX Jiang… - Journal of Clinical …, 2022 - europepmc.org
Methods PubMed Central/Medline, Embase and cochrane library were systematically
searched for randomized controlled trials and single-arm clinical trials on aflibercept plus …
searched for randomized controlled trials and single-arm clinical trials on aflibercept plus …